Plasma Exposure to Insulin Glargine and Its Metabolites M1 and M2 After Subcutaneous Injection of Therapeutic and Supratherapeutic Doses of Glargine in Subjects With Type 1 Diabete... von BOLLI, Geremia B, HAHN, Annke D, SCHMIDT, Ronald, EISENBLAETTER, Tanja, DAHMEN, Raphael, HEISE, Tim, BECKER, Reinhard H. A

Volltext

Clinical Pharmacokinetics and Pharmacodynamics of Insulin Glulisine von Becker, Reinhard H. A., Frick, Annke D.

Volltext

Similar pharmacokinetics and pharmacodynamics of rapid‐acting insulin lispro products SAR342434 and US‐ and EU‐approved Humalog in subjects with type 1 diabetes von Kapitza, Christoph, Nowotny, Irene, Lehmann, Anne, Bergmann, Karin, Rotthaeuser, Baerbel, Nosek, Leszek, Becker, Reinhard H. A.

Volltext

Effects of lixisenatide once daily on gastric emptying in type 2 diabetes — Relationship to postprandial glycemia von Lorenz, Martin, Pfeiffer, Claudia, Steinsträßer, Axel, Becker, Reinhard H.A., Rütten, Hartmut, Ruus, Peter, Horowitz, Michael

Volltext

In response to: Heise T, Nørskov M, Nosek L, Kaplan K, Famulla S and Haahr H. L. (2017) Insulin degludec: Lower day‐to‐day and within‐day variability in pharmacodynamic response co... von Becker, Reinhard H.A.

Volltext

Lixisenatide reduces postprandial hyperglycaemia via gastrostatic and insulinotropic effects von Becker, Reinhard H. A., Stechl, Jens, Steinstraesser, Axel, Golor, Georg, Pellissier, Franck

Volltext

Time-Action Profile of Inhaled Insulin in Comparison With Subcutaneously Injected Insulin Lispro and Regular Human Insulin von Rave, Klaus, Bott, Susanne, Heinemann, Lutz, Sha, Sue, Becker, Reinhard H.A, Willavize, Susan A, Heise, Tim

Volltext

Pharmacokinetics, Prandial Glucose Control, and Safety of Insulin Glulisine in Children and Adolescents With Type 1 Diabetes von Danne, Thomas, Becker, Reinhard H. A, Heise, Tim, Bittner, Claudia, Frick, Annke D, Rave, Klaus

Volltext

Advantage of Premeal-Injected Insulin Glulisine Compared With Regular Human Insulin in Subjects With Type 1 Diabetes von Rave, Klaus, Klein, Oliver, Frick, Annke D, Becker, Reinhard H.A

Volltext

The Effect of Smoking Cessation and Subsequent Resumption on Absorption of Inhaled Insulin von BECKER, Reinhard H. A, SHA, Sue, FRICK, Annke D, FOUNTAINE, Robert J

Volltext

Dose-Response Relationship of Insulin Glulisine in Subjects With Type 1 Diabetes von Becker, Reinhard H.A, Frick, Annke D, Nosek, Leszek, Heinemann, Lutz, Rave, Klaus

Volltext

Insulin glargine metabolite 21(A) -Gly-human insulin (M1) is the principal component circulating in the plasma of young children with type 1 diabetes: results from the PRESCHOOL st... von Danne, Thomas, Becker, Reinhard H A, Ping, Lin, Philotheou, Areti

Volltext

New insulin glargine 300 Units · mL-1 provides a more even activity profile and prolonged glycemic control at steady state compared with insulin glargine 100 Units · mL-1 von Becker, Reinhard H A, Dahmen, Raphael, Bergmann, Karin, Lehmann, Anne, Jax, Thomas, Heise, Tim

Volltext

Insulin depot absorption modeling and pharmacokinetic simulation with insulin glargine 300 U/mL von Lindauer, Klaus, Becker, Reinhard

Volltext

Long-term ACE inhibition doubles lifespan of hypertensive rats von LINZ, W, JESSEN, T, BECKER, R. H. A, SHÖLKENS, B. A, WIEMER, G

Volltext

Late Treatment With Ramipril Increases Survival in Old Spontaneously Hypertensive Rats von Linz, Wolfgang, Wohlfart, Paulus, Schoelkens, Bernward A, Becker, Reinhard H.A, Malinski, Tadeusz, Wiemer, Gabriele

Volltext

Ramiprilat Enhances Endothelial Autacoid Formation by Inhibiting Breakdown of Endothelium-Derived Bradykinin von Wiemer, Gabriele, Scholkens, Bemward A, Becker, Reinhard H.A, Busse, Rudi

Volltext

Reply von Becker, Reinhard

Volltext

Reply von Becker, Reinhard

Volltext

New Insulin Glargine 300 Units·mL^sup-1^ Provides a More Even Activity Profile and Prolonged Glycemic Control at Steady State Compared With Insulin Glargine 100 Units·mL^sup -1 von Becker, Reinhard HA, Dahmen, Raphael, Bergmann, Karin, Lehmann, Anne, Jax, Thomas, Heise, Tim

Volltext